Physician profile
Alexander Evans
NPI 1407939754
$16,424.02
in general payments reported to CMS, 2019-2025
24 companies · $1,603 in 2025
The $1,603 reported for 2025 was more than what 76% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $765 · 2021: $9,729 · 2022: $1,200 · 2023: $1,657 · 2024: $655 · 2025: $1,603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,385 · Education: $1,500 · Travel and Lodging: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,384.54 |
| Education | $1,500.00 |
| Travel and Lodging | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $12,013.12 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Intuitive Surgical, INC. | $1,584.16 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $716.92 | 2019-2024 | Advantagerib |
| W. L. Gore & Associates, INC. | $440.92 | 2024-2025 | Gore Synecor Preperitoneal Biomaterial, Gore Enform Intraperitoneal Biomaterial, Gore Synecor Biomaterial |
| Hemosonics LLC | $197.40 | 2024-2025 | Quantra Qplus System, Qunatra Qplus System |
| Acera Surgical, INC. | $186.44 | 2025 | Restrata Wound Matrix |
| Baxter Healthcare | $133.19 | 2025 | Floseal |
| Medical Device Business Services, INC. | $125.04 | 2019 | |
| Portola Pharmaceuticals, LLC | $117.98 | 2019-2020 | |
| Haemonetics Corporation | $117.58 | 2024 | Teg6s Hemostasis System |
| Globus Medical, INC. | $106.19 | 2025 | Creo, Excelsius Gps, Colosseum |
| Olympus America INC. | $105.76 | 2024 | Hanarostent Esophagus Tts(Ccc) |
| Amgen INC. | $103.24 | 2019 | |
| Integra Lifesciences Corporation | $92.47 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $72.73 | 2023 | Abthera Advance |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $61.53 | 2025 | Flexitouch Plus, Nimbl |
| Smith+Nephew, INC. | $44.44 | 2019-2025 | Collagenase Santyl |
| Ethicon US, LLC | $40.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $37.02 | 2024-2025 | Andexxa, Breztri |
| Depuy Synthes Sales INC. | $30.40 | 2019 | |
| Biocomposites INC | $30.03 | 2019 | |
| Corcept Therapeutics | $27.60 | 2025 | Korlym |
| Solventum Corporation | $25.13 | 2025 | Abthera Advance |
| Davol INC. | $13.98 | 2024 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.